Centrum Medyczne ENEL-MED S.A. (FRA:E19)
Germany · Delayed Price · Currency is EUR 4.000
-0.020 (-0.50%)
At close: Nov 28, 2025
Centrum Medyczne ENEL-MED Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 820.59 | 735.59 | 616.77 | 494.9 | 441.14 | 399.8 | Upgrade |
| 820.59 | 735.59 | 616.77 | 494.9 | 441.14 | 399.8 | Upgrade | |
Revenue Growth (YoY) | 15.52% | 19.27% | 24.62% | 12.19% | 10.34% | -4.28% | Upgrade |
Cost of Revenue | 746.13 | 677.09 | 589.43 | 484.02 | 419 | 369.5 | Upgrade |
Gross Profit | 74.47 | 58.51 | 27.34 | 10.88 | 22.14 | 30.3 | Upgrade |
Selling, General & Admin | 51.39 | 35.54 | 32.9 | 37.12 | 23.82 | 20.23 | Upgrade |
Other Operating Expenses | 3.72 | 0.08 | -9.07 | -6.54 | -3.73 | -3.3 | Upgrade |
Operating Expenses | 55.11 | 35.62 | 23.84 | 30.58 | 20.09 | 16.93 | Upgrade |
Operating Income | 19.36 | 22.89 | 3.5 | -19.7 | 2.06 | 13.37 | Upgrade |
Interest Expense | -9.68 | -10.39 | -10.16 | -5.82 | -5.33 | -7.52 | Upgrade |
Interest & Investment Income | 1.24 | 1.24 | 1.64 | 2.46 | 1.64 | 1.09 | Upgrade |
Currency Exchange Gain (Loss) | 3.12 | 3.12 | 14.61 | -2.83 | 0.61 | -9.98 | Upgrade |
Other Non Operating Income (Expenses) | -4.98 | -2.05 | -0.02 | -0.01 | -0.01 | -0.03 | Upgrade |
EBT Excluding Unusual Items | 9.06 | 14.82 | 9.57 | -25.89 | -1.03 | -3.07 | Upgrade |
Merger & Restructuring Charges | 3.55 | 3.55 | - | - | - | - | Upgrade |
Gain (Loss) on Sale of Investments | -0.01 | -0.01 | -0.04 | -0.77 | - | -3.24 | Upgrade |
Gain (Loss) on Sale of Assets | -0.13 | -0.13 | -3.72 | -1.28 | -0.1 | -0.97 | Upgrade |
Legal Settlements | -0 | -0 | -0.04 | - | -0.02 | -0 | Upgrade |
Other Unusual Items | 0.93 | 0.93 | 3.13 | - | 1.24 | 2.8 | Upgrade |
Pretax Income | 13.39 | 19.14 | 8.89 | -27.94 | 0.1 | -4.48 | Upgrade |
Income Tax Expense | 2.98 | 4.54 | 0.97 | -4.38 | 1.51 | -1.08 | Upgrade |
Earnings From Continuing Operations | 10.4 | 14.61 | 7.93 | -23.56 | -1.41 | -3.4 | Upgrade |
Net Income | 10.4 | 14.61 | 7.93 | -23.56 | -1.41 | -3.4 | Upgrade |
Net Income to Common | 10.4 | 14.61 | 7.93 | -23.56 | -1.41 | -3.4 | Upgrade |
Net Income Growth | -32.87% | 84.27% | - | - | - | - | Upgrade |
Shares Outstanding (Basic) | 28 | 28 | 28 | 28 | 24 | 24 | Upgrade |
Shares Outstanding (Diluted) | 28 | 28 | 28 | 28 | 24 | 24 | Upgrade |
Shares Change (YoY) | 0.29% | - | - | 17.55% | 2.08% | - | Upgrade |
EPS (Basic) | 0.37 | 0.52 | 0.28 | -0.83 | -0.06 | -0.14 | Upgrade |
EPS (Diluted) | 0.37 | 0.52 | 0.28 | -0.83 | -0.06 | -0.14 | Upgrade |
EPS Growth | -32.08% | 84.49% | - | - | - | - | Upgrade |
Free Cash Flow | 52.53 | 58.34 | 55.17 | -5.9 | 28.55 | 63.44 | Upgrade |
Free Cash Flow Per Share | 1.85 | 2.06 | 1.95 | -0.21 | 1.19 | 2.69 | Upgrade |
Gross Margin | 9.07% | 7.95% | 4.43% | 2.20% | 5.02% | 7.58% | Upgrade |
Operating Margin | 2.36% | 3.11% | 0.57% | -3.98% | 0.47% | 3.34% | Upgrade |
Profit Margin | 1.27% | 1.99% | 1.29% | -4.76% | -0.32% | -0.85% | Upgrade |
Free Cash Flow Margin | 6.40% | 7.93% | 8.95% | -1.19% | 6.47% | 15.87% | Upgrade |
EBITDA | 52.26 | 51.14 | 29.63 | 5.53 | 24.79 | 35.69 | Upgrade |
EBITDA Margin | 6.37% | 6.95% | 4.80% | 1.12% | 5.62% | 8.93% | Upgrade |
D&A For EBITDA | 32.9 | 28.25 | 26.13 | 25.22 | 22.73 | 22.33 | Upgrade |
EBIT | 19.36 | 22.89 | 3.5 | -19.7 | 2.06 | 13.37 | Upgrade |
EBIT Margin | 2.36% | 3.11% | 0.57% | -3.98% | 0.47% | 3.34% | Upgrade |
Effective Tax Rate | 22.28% | 23.69% | 10.86% | - | 1568.75% | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.